Building an Effective Exercise Program A well-designed exercise program during GLP-1 therapy includes both resistance training and cardiovascular activity
Medical monitoring and assessment should be individualized based on risk factors
Wegovy dosing goes from 0.25 mg to 0.5 mg to 1.0 mg to 1.7 mg to 2.4 mg
Our team of dedicated healthcare professionals is deeply committed to providing comprehensive care and support, ensuring you have the guidance needed to achieve your goals
For many people over 50, years of dieting, calorie counting, and fighting cravings have left you feeling stuck
262-OR: Pemvidutide, a GLP-1/glucagon dual receptor agonist, in subjects with overweight or obesitya 48-week, placebo-controlled, phase 2 (MOMENTUM) trial